Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-15 Sale | 2024-11-18 4:03 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 6,500 | $57.7 | $375,050 | 76,777 (Direct) | View |
| 2024-11-13 Sale | 2024-11-14 4:16 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $61.36 | $15,340 | 56,238 (Direct) | View |
| 2024-10-14 Sale | 2024-10-15 5:57 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $57.19 | $14,298 | 56,488 (Direct) | View |
| 2024-09-13 Sale | 2024-09-16 4:50 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $56.82 | $14,205 | 56,738 (Direct) | View |
| 2024-08-13 Sale | 2024-08-14 08:29 am | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $59.62 | $14,905 | 56,988 (Direct) | View |
| 2024-07-18 Sale | 2024-07-19 5:30 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 2,743 | $62 | $170,066 | 706,272 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 7:07 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 47,257 | $63.73 | $3,011,592 | 709,015 (Indirect Direct) | View |
| 2024-07-12 Sale | 2024-07-15 4:38 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $64.91 | $16,228 | 58,981 (Direct) | View |
| 2024-07-01 Sale | 2024-07-02 8:58 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $63.44 | $1,268,800 | 242,905 (Indirect Direct) | View |
| 2024-06-21 Sale | 2024-06-24 4:12 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 20,000 | $58.9 | $1,178,000 | 756,272 (Indirect Direct) | View |
| 2024-06-17 Sale | 2024-06-20 7:11 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 30,000 | $60.59 | $1,817,663 | 776,272 (Indirect Direct) | View |
| 2024-06-13 Sale | 2024-06-14 5:23 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $63.8 | $15,950 | 59,231 (Direct) | View |
| 2024-06-05 Sale | 2024-06-06 6:21 pm | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 2,985 | $67 | $199,995 | 77,227 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 07:34 am | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 5,000 | $63.58 | $317,900 | 161,968 (Direct) | View |
| 2024-06-03 Sale | 2024-06-04 6:08 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $64.41 | $1,288,200 | 262,905 (Indirect Direct) | View |
| 2024-05-21 Sale | 2024-05-22 6:14 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,000 | $61.61 | $123,220 | 83,277 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:21 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 12,855 | $61.81 | $794,568 | 806,272 (Indirect Direct) | View |
| 2024-05-15 Sale | 2024-05-17 6:05 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 37,145 | $64.37 | $2,391,121 | 819,127 (Indirect Direct) | View |
| 2024-05-16 Sale | 2024-05-17 6:01 pm | ANI PHARMACEUTICALS INC | ANIP | TANNENBAUM RENEE P Director | 2,000 | $63.87 | $127,740 | 18,211 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 5:02 pm | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 16,669 | $66.1 | $1,101,821 | 377,505 (Direct) | View |
| 2024-05-13 Sale | 2024-05-13 5:25 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $67.69 | $16,923 | 59,481 (Direct) | View |
| 2024-05-01 Sale | 2024-05-03 5:48 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $66.62 | $1,332,400 | 282,905 (Indirect Direct) | View |
| 2024-04-18 Sale | 2024-04-22 6:26 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 27,232 | $65.1 | $1,772,729 | 856,272 (Indirect Direct) | View |
| 2024-04-15 Sale | 2024-04-17 4:33 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 22,768 | $65.91 | $1,500,589 | 883,504 (Indirect Direct) | View |
| 2024-04-12 Sale | 2024-04-15 6:28 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $67.79 | $16,948 | 59,731 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:59 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $67.25 | $1,345,000 | 302,905 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-15 Tax Withholding | 2024-11-18 4:05 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 867 | $56.58 | 33,169 (Direct) | View |
| 2024-09-12 Tax Withholding | 2024-09-13 4:23 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 1,486 | $56.15 | 50,059 (Direct) | View |
| 2024-09-08 Tax Withholding | 2024-09-10 4:44 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 3,646 | $60.51 | 373,859 (Direct) | View |
| 2024-07-18 Tax Withholding | 2024-07-19 5:27 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 1,743 | $61.35 | 57,238 (Direct) | View |
| 2024-06-07 Exercise | 2024-06-11 4:51 pm | N/A 2028-04-05 | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 5,300 | $57.06 | 117,829 (Direct) | View |
| 2024-06-07 Exercise | 2024-06-11 4:51 pm | N/A 2027-03-30 | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 7,250 | $49.51 | 117,829 (Direct) | View |
| 2024-06-07 Tax Withholding | 2024-06-11 4:51 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 11,087 | $67.7 | 117,829 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 8:03 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Walsh Patrick D Director | 4,410 | $0 | 74,712 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 8:02 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Thoma Jeanne Director | 4,410 | $0 | 40,609 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 7:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | TANNENBAUM RENEE P Director | 4,410 | $0 | 22,621 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 7:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Pera Antonio R Director | 4,410 | $0 | 31,037 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 7:54 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Leonard Matthew J Director | 4,410 | $0 | 11,993 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 7:45 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | HAUGHEY THOMAS Director | 4,410 | $0 | 51,526 (Direct) | View |
| 2024-04-10 Tax Withholding | 2024-04-11 9:13 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 2,799 | $66.96 | 116,006 (Direct) | View |
| 2024-04-10 Tax Withholding | 2024-04-11 9:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 4,534 | $66.96 | 166,968 (Direct) | View |
Ownership | 2024-04-08 9:53 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 0 | $0 | 34,036 (Direct) | View |